NCT07213726

Brief Summary

The purpose of this observational study is to examine how slowing down blood flow to the legs- a practice called blood flow restriction (BFR)- during exercise by applying compression to the legs affects the way stem cells are released into the blood stream. This will be determined by drawing 6 cubic centimeters (ccs) of blood immediately post-exercise after the Delfi Personalized Tourniquet System (PTS) has been removed. 6 ccs of blood will also be taken prior to exercise and at the 20-, 40-, and 60-minute marks after exercise. The main question of this study is:

  • Will the levels of stem cells extracted before and after exercise be the same if blood flow is restricted during exercise? In this study, participants will undergo the following:
  • 6 ccs of blood extracted from the forearm prior to exercise to establish a baseline
  • 3 exercises- seated leg extension, semi-reclined leg press, and seated hamstring curl- consisting of 4 sets of 30-15-15-15 repetitions per exercise; resistance will be set to 30% of one-rep maximum (1-RM)
  • Additional 6 cc blood draws will be performed immediately post-exercise and after 20, 40, and 60 minutes have elapsed

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Aug 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Aug 2022Nov 2026

Study Start

First participant enrolled

August 16, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 28, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2023

Completed
1.9 years until next milestone

First Posted

Study publicly available on registry

October 9, 2025

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2026

Expected
Last Updated

December 8, 2025

Status Verified

December 1, 2025

Enrollment Period

1.3 years

First QC Date

October 28, 2022

Last Update Submit

December 1, 2025

Conditions

Outcome Measures

Primary Outcomes (12)

  • Concentration of Blood Lactate

    Allows researchers insight into each subject's exertion level reflected by the amount of lactate found within the samples collected.

    1 week after enrollment

  • Concentration of Blood Lactate

    Allows researchers insight into each subject's exertion level reflected by the amount of lactate found within the samples collected.

    2 weeks after enrollment

  • Concentration of Blood Lactate

    Allows researchers insight into each subject's exertion level reflected by the amount of lactate found within the samples collected.

    3 weeks after enrollment

  • Concentration of Blood Lactate

    Allows researchers insight into each subject's exertion level reflected by the amount of lactate found within the samples collected.

    4 weeks after enrollment

  • Concentration of Blood Lactate

    Allows researchers insight into each subject's exertion level reflected by the amount of lactate found within the samples collected.

    5 weeks after enrollment

  • Concentration of Blood Lactate

    Allows researchers insight into each subject's exertion level reflected by the amount of lactate found within the samples collected.

    6 weeks after enrollment

  • Prevalence of Hematopoietic Stem Cells

    Technique completed using special machine that utilizes lasers to separate and quantify various content of cell samples; used in this study to determine complete blood cell count (CBC) and peripheral hematopoietic progenitor cell concentration

    1 week after enrollment

  • Prevalence of Hematopoietic Stem Cells

    Technique completed using special machine that utilizes lasers to separate and quantify various content of cell samples; used in this study to determine complete blood cell count (CBC) and peripheral hematopoietic progenitor cell concentration

    2 weeks after enrollment

  • Prevalence of Hematopoietic Stem Cells

    Technique completed using special machine that utilizes lasers to separate and quantify various content of cell samples; used in this study to determine complete blood cell count (CBC) and peripheral hematopoietic progenitor cell concentration

    3 weeks after enrollment

  • Prevalence of Hematopoietic Stem Cells

    Technique completed using special machine that utilizes lasers to separate and quantify various content of cell samples; used in this study to determine complete blood cell count (CBC) and peripheral hematopoietic progenitor cell concentration

    4 weeks after enrollment

  • Prevalence of Hematopoietic Stem Cells

    Technique completed using special machine that utilizes lasers to separate and quantify various content of cell samples; used in this study to determine complete blood cell count (CBC) and peripheral hematopoietic progenitor cell concentration

    5 weeks after enrollment

  • Prevalence of Hematopoietic Stem Cells

    Technique completed using special machine that utilizes lasers to separate and quantify various content of cell samples; used in this study to determine complete blood cell count (CBC) and peripheral hematopoietic progenitor cell concentration

    6 weeks after enrollment

Study Arms (1)

Healthy

EXPERIMENTAL

This group consists of all participants in this study. Subjects must be healthy, and gender is not a factor for enrollment.

Device: Delfi Personalized Tourniquet System

Interventions

Bilateral proximal thigh bands that will be applied and inflated to a pressure of 80% of occlusive pressure as determined by the automated tourniquet before exercise. A standard exercise session would not include any blood occlusion.

Healthy

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Volunteer population of healthy males and females aged 18-45.
  • Subjects consent to attending a total of 14 visits over a time span of seven to nine weeks. The breakdown of the 14 visits is as follows: 1 familiarization session, 12 experimental testing sessions, 1 final session.

You may not qualify if:

  • Volunteers who have medical history involving one or more of the following medical conditions:
  • Diabetes
  • Uncontrolled hypertension
  • Autoimmune disorders
  • Blood disorders
  • Ongoing infectious disease
  • Cancer
  • Any disorder requiring immunosuppression treatment
  • Steroid usage
  • Significant cardiovascular, pulmonary, hepatic, or renal disease.
  • Volunteers where 20 minutes of intense exercise is contra-indicated will also be excluded from the study.
  • Positive pregnancy test

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Andrews Institute for Orthopaedics & Sports Medicine

Gulf Breeze, Florida, 32561, United States

Location

Related Publications (32)

  • Weissman IL, Shizuru JA. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood. 2008 Nov 1;112(9):3543-53. doi: 10.1182/blood-2008-08-078220.

    PMID: 18948588BACKGROUND
  • Zakrzewski JL, van den Brink MR, Hubbell JA. Overcoming immunological barriers in regenerative medicine. Nat Biotechnol. 2014 Aug;32(8):786-94. doi: 10.1038/nbt.2960.

    PMID: 25093888BACKGROUND
  • Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991 Sep;9(5):641-50. doi: 10.1002/jor.1100090504.

    PMID: 1870029BACKGROUND
  • Marycz K, Mierzejewska K, Smieszek A, Suszynska E, Malicka I, Kucia M, Ratajczak MZ. Endurance Exercise Mobilizes Developmentally Early Stem Cells into Peripheral Blood and Increases Their Number in Bone Marrow: Implications for Tissue Regeneration. Stem Cells Int. 2016;2016:5756901. doi: 10.1155/2016/5756901. Epub 2015 Nov 9.

    PMID: 26664409BACKGROUND
  • Agha NH, Baker FL, Kunz HE, Graff R, Azadan R, Dolan C, Laughlin MS, Hosing C, Markofski MM, Bond RA, Bollard CM, Simpson RJ. Vigorous exercise mobilizes CD34+ hematopoietic stem cells to peripheral blood via the beta2-adrenergic receptor. Brain Behav Immun. 2018 Feb;68:66-75. doi: 10.1016/j.bbi.2017.10.001. Epub 2017 Oct 7.

    PMID: 29017969BACKGROUND
  • Callanan MC, Plummer HA, Chapman GL, Opitz TJ, Rendos NK, Anz AW. Blood Flow Restriction Training Using the Delfi System Is Associated With a Cellular Systemic Response. Arthrosc Sports Med Rehabil. 2020 Dec 27;3(1):e189-e198. doi: 10.1016/j.asmr.2020.09.009. eCollection 2021 Feb.

    PMID: 33615264BACKGROUND
  • Hwang NS, Zhang C, Hwang YS, Varghese S. Mesenchymal stem cell differentiation and roles in regenerative medicine. Wiley Interdiscip Rev Syst Biol Med. 2009 Jul-Aug;1(1):97-106. doi: 10.1002/wsbm.26.

    PMID: 20835984BACKGROUND
  • Docheva D, Popov C, Mutschler W, Schieker M. Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin system. J Cell Mol Med. 2007 Jan-Feb;11(1):21-38. doi: 10.1111/j.1582-4934.2007.00001.x.

    PMID: 17367499BACKGROUND
  • Rochefort GY, Delorme B, Lopez A, Herault O, Bonnet P, Charbord P, Eder V, Domenech J. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells. 2006 Oct;24(10):2202-8. doi: 10.1634/stemcells.2006-0164. Epub 2006 Jun 15.

    PMID: 16778152BACKGROUND
  • Hylden C, Burns T, Stinner D, Owens J. Blood flow restriction rehabilitation for extremity weakness: a case series. J Spec Oper Med. 2015 Spring;15(1):50-6.

    PMID: 25770798BACKGROUND
  • Takarada Y, Takazawa H, Ishii N. Applications of vascular occlusion diminish disuse atrophy of knee extensor muscles. Med Sci Sports Exerc. 2000 Dec;32(12):2035-9. doi: 10.1097/00005768-200012000-00011.

    PMID: 11128848BACKGROUND
  • Vechin FC, Libardi CA, Conceicao MS, Damas FR, Lixandrao ME, Berton RP, Tricoli VA, Roschel HA, Cavaglieri CR, Chacon-Mikahil MP, Ugrinowitsch C. Comparisons between low-intensity resistance training with blood flow restriction and high-intensity resistance training on quadriceps muscle mass and strength in elderly. J Strength Cond Res. 2015 Apr;29(4):1071-6. doi: 10.1519/JSC.0000000000000703.

    PMID: 25264670BACKGROUND
  • Takarada Y, Takazawa H, Sato Y, Takebayashi S, Tanaka Y, Ishii N. Effects of resistance exercise combined with moderate vascular occlusion on muscular function in humans. J Appl Physiol (1985). 2000 Jun;88(6):2097-106. doi: 10.1152/jappl.2000.88.6.2097.

    PMID: 10846023BACKGROUND
  • Feriche B, Garcia-Ramos A, Morales-Artacho AJ, Padial P. Resistance Training Using Different Hypoxic Training Strategies: a Basis for Hypertrophy and Muscle Power Development. Sports Med Open. 2017 Dec;3(1):12. doi: 10.1186/s40798-017-0078-z. Epub 2017 Mar 17.

    PMID: 28315193BACKGROUND
  • Kaijser L, Sundberg CJ, Eiken O, Nygren A, Esbjornsson M, Sylven C, Jansson E. Muscle oxidative capacity and work performance after training under local leg ischemia. J Appl Physiol (1985). 1990 Aug;69(2):785-7. doi: 10.1152/jappl.1990.69.2.785.

    PMID: 2146245BACKGROUND
  • Farup J, de Paoli F, Bjerg K, Riis S, Ringgard S, Vissing K. Blood flow restricted and traditional resistance training performed to fatigue produce equal muscle hypertrophy. Scand J Med Sci Sports. 2015 Dec;25(6):754-63. doi: 10.1111/sms.12396. Epub 2015 Jan 21.

    PMID: 25603897BACKGROUND
  • Ellefsen S, Hammarstrom D, Strand TA, Zacharoff E, Whist JE, Rauk I, Nygaard H, Vegge G, Hanestadhaugen M, Wernbom M, Cumming KT, Ronning R, Raastad T, Ronnestad BR. Blood flow-restricted strength training displays high functional and biological efficacy in women: a within-subject comparison with high-load strength training. Am J Physiol Regul Integr Comp Physiol. 2015 Oct;309(7):R767-79. doi: 10.1152/ajpregu.00497.2014. Epub 2015 Jul 22.

    PMID: 26202071BACKGROUND
  • de Freitas MC, Gerosa-Neto J, Zanchi NE, Lira FS, Rossi FE. Role of metabolic stress for enhancing muscle adaptations: Practical applications. World J Methodol. 2017 Jun 26;7(2):46-54. doi: 10.5662/wjm.v7.i2.46. eCollection 2017 Jun 26.

    PMID: 28706859BACKGROUND
  • Vanwye WR, Weatherholt AM, Mikesky AE. Blood Flow Restriction Training: Implementation into Clinical Practice. Int J Exerc Sci. 2017 Sep 1;10(5):649-654. doi: 10.70252/LYGQ7085. eCollection 2017.

    PMID: 28966705BACKGROUND
  • Loenneke JP, Fahs CA, Rossow LM, Abe T, Bemben MG. The anabolic benefits of venous blood flow restriction training may be induced by muscle cell swelling. Med Hypotheses. 2012 Jan;78(1):151-4. doi: 10.1016/j.mehy.2011.10.014. Epub 2011 Nov 1.

    PMID: 22051111BACKGROUND
  • Wilson JM, Lowery RP, Joy JM, Loenneke JP, Naimo MA. Practical blood flow restriction training increases acute determinants of hypertrophy without increasing indices of muscle damage. J Strength Cond Res. 2013 Nov;27(11):3068-75. doi: 10.1519/JSC.0b013e31828a1ffa.

    PMID: 23446173BACKGROUND
  • Loenneke JP, Abe T, Wilson JM, Thiebaud RS, Fahs CA, Rossow LM, Bemben MG. Blood flow restriction: an evidence based progressive model (Review). Acta Physiol Hung. 2012 Sep;99(3):235-50. doi: 10.1556/APhysiol.99.2012.3.1.

    PMID: 22982712BACKGROUND
  • Reeves GV, Kraemer RR, Hollander DB, Clavier J, Thomas C, Francois M, Castracane VD. Comparison of hormone responses following light resistance exercise with partial vascular occlusion and moderately difficult resistance exercise without occlusion. J Appl Physiol (1985). 2006 Dec;101(6):1616-22. doi: 10.1152/japplphysiol.00440.2006. Epub 2006 Aug 10.

    PMID: 16902061BACKGROUND
  • Inagaki Y, Madarame H, Neya M, Ishii N. Increase in serum growth hormone induced by electrical stimulation of muscle combined with blood flow restriction. Eur J Appl Physiol. 2011 Nov;111(11):2715-21. doi: 10.1007/s00421-011-1899-y. Epub 2011 Mar 12.

    PMID: 21399959BACKGROUND
  • Schoenfeld BJ. Potential mechanisms for a role of metabolic stress in hypertrophic adaptations to resistance training. Sports Med. 2013 Mar;43(3):179-94. doi: 10.1007/s40279-013-0017-1.

    PMID: 23338987BACKGROUND
  • Pearson SJ, Hussain SR. A review on the mechanisms of blood-flow restriction resistance training-induced muscle hypertrophy. Sports Med. 2015 Feb;45(2):187-200. doi: 10.1007/s40279-014-0264-9.

    PMID: 25249278BACKGROUND
  • Manini TM, Yarrow JF, Buford TW, Clark BC, Conover CF, Borst SE. Growth hormone responses to acute resistance exercise with vascular restriction in young and old men. Growth Horm IGF Res. 2012 Oct;22(5):167-72. doi: 10.1016/j.ghir.2012.05.002. Epub 2012 Jun 23.

    PMID: 22727808BACKGROUND
  • Takano H, Morita T, Iida H, Asada K, Kato M, Uno K, Hirose K, Matsumoto A, Takenaka K, Hirata Y, Eto F, Nagai R, Sato Y, Nakajima T. Hemodynamic and hormonal responses to a short-term low-intensity resistance exercise with the reduction of muscle blood flow. Eur J Appl Physiol. 2005 Sep;95(1):65-73. doi: 10.1007/s00421-005-1389-1. Epub 2005 Jun 15.

    PMID: 15959798BACKGROUND
  • Takarada Y, Nakamura Y, Aruga S, Onda T, Miyazaki S, Ishii N. Rapid increase in plasma growth hormone after low-intensity resistance exercise with vascular occlusion. J Appl Physiol (1985). 2000 Jan;88(1):61-5. doi: 10.1152/jappl.2000.88.1.61.

    PMID: 10642363BACKGROUND
  • Ganesan G, Cotter JA, Reuland W, Cerussi AE, Tromberg BJ, Galassetti P. Effect of blood flow restriction on tissue oxygenation during knee extension. Med Sci Sports Exerc. 2015 Jan;47(1):185-93. doi: 10.1249/MSS.0000000000000393.

    PMID: 24870580BACKGROUND
  • Scott BR, Slattery KM, Sculley DV, Dascombe BJ. Hypoxia and resistance exercise: a comparison of localized and systemic methods. Sports Med. 2014 Aug;44(8):1037-54. doi: 10.1007/s40279-014-0177-7.

    PMID: 24715613BACKGROUND
  • Narici MV, Kayser B. Hypertrophic response of human skeletal muscle to strength training in hypoxia and normoxia. Eur J Appl Physiol Occup Physiol. 1995;70(3):213-9. doi: 10.1007/BF00238566.

    PMID: 7607195BACKGROUND

Study Officials

  • Tyler Opitz, DPT, SCS, CSCS

    Physical Therapist

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 28, 2022

First Posted

October 9, 2025

Study Start

August 16, 2022

Primary Completion

November 20, 2023

Study Completion (Estimated)

November 20, 2026

Last Updated

December 8, 2025

Record last verified: 2025-12

Locations